Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Brother Pharmaceutical is a major Chinese manufacturer specializing in the production of vitamins and active pharmaceutical ingredients (APIs). As a key subsidiary of Brother Enterprises Holding, the company operates large-scale production facilities for Vitamin B1 (thiamine), Vitamin B3 (niacin and nicotinamide), and Vitamin B5 (calcium pantothenate). Its operations are centered in the Pengze County Industrial Park in Jiangxi Province, where it utilizes advanced chemical synthesis and fermentation technologies. The company serves a global clientele across the pharmaceutical, food additive, and animal nutrition sectors, maintaining compliance with international GMP standards. Jiangxi Brother Pharmaceutical is a critical component of its parent company's strategy to dominate the global vitamin B-series market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Brother Pharmaceutical.